InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
6
Disclosed sells
2
T+90 hit rate
57%
T+90 mean return
+4.2%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Corley Jesse Anderson. Director active across 1 company, notably RxSight, Inc.. In total, 17 reports have been logged. Breakdown: 6 buys · 2 sells. Total volume traded: €3.3m. Activity tracked since 30 July 2021. The latest transaction was disclosed on 15 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations17 total
37,037 sharesCommon StockSEC:0001193125-26-275837:0
1,443 shares@ US$31.1851.3% of flowCommon StockSEC:0000950170-25-006858:0
Ideal exit: 12 Oct 2025 (T+270)
11,111 shares@ US$45.367614.5% of flowCommon StockSEC:0000950170-24-127339:0
Ideal exit: 9 Aug 2025 (T+270)
2,554 sharesCommon StockSEC:0000950170-24-071294:0
46,884 shares0Common StockSEC:0000950170-24-012451:0
2,000 shares@ US$45.02932.5% of flowCommon StockSEC:0000950170-24-003324:0
10,000 shares@ US$40.122411.3% of flowCommon StockSEC:0001209191-23-059040:0
81,450 shares0Common StockSEC:0001209191-23-055420:0
1,204 shares0Common StockSEC:0001209191-23-046644:0
5,731 shares0Common StockSEC:0001209191-23-034299:0
10,349 shares0Common StockSEC:0001209191-22-034388:0
8,150 shares@ US$12.4850.038% mcap3.9% of flowCommon StockSEC:0000899243-21-045279:0
Ideal exit: 14 Aug 2022 (T+270)
8,150 shares@ US$12.4852.8% of flowCommon StockSEC:0000899243-21-045279
Ideal exit: 14 Aug 2022 (T+270)
78,125 shares@ US$16.000.45% mcap46.1% of flowCommon StockSEC:0000899243-21-031823:0
Ideal exit: 30 Apr 2022 (T+270)
78,125 shares@ US$16.0032.4% of flowCommon StockSEC:0000899243-21-031823
Ideal exit: 30 Apr 2022 (T+270)
5,859 shares0Common StockSEC:0000899243-21-031098
5,859 shares0Common StockSEC:0000899243-21-031098:0
17 of 17 declarations
About Corley Jesse Anderson
Corley Jesse Anderson is a Director at RxSight, Inc. (XNAS). The declarant has 17 filings in total, and across the recent sampled filings held, buys amount to EUR 2802342 and sells to EUR 450868, between 2021-08-02 and 2026-06-18. The modal transaction nature is Attribution.
